Pluri (PLUR) Assets Average (2011 - 2025)
Pluri (PLUR) reported Assets Average of $32.1 million for Q4 2025, down 3.07% year-over-year from $33.2 million in Q4 2024, and down 11.18% quarter-over-quarter from $36.2 million in Q3 2025.
Pluri (PLUR) Assets Average (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Assets Average data on file, last reported at $32.1 million in Q4 2025.
- Assets Average for Q4 2025 came in at $32.1 million, down 3.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.1 million (down 3.07% YoY), and the FY2025 annual result was $39.1 million, down 13.41% from the prior year.
- Assets Average slipped to $32.1 million in Q4 2025 per PLUR's latest filing, from $36.2 million in the prior quarter.
- Over five years, Assets Average peaked at $88.6 million in Q3 2021 and troughed at $32.1 million in Q4 2025.
- A 5-year average of $54.6 million and a median of $50.6 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2021 and 2024: Assets Average surged 174.51% in 2021, then tumbled 32.9% in 2024.
- A 5-year view of Assets Average shows it stood at $82.5 million in 2021, then slipped by 27.44% to $59.8 million in 2022, then dropped by 28.05% to $43.1 million in 2023, then decreased by 23.0% to $33.2 million in 2024, then retreated by 3.07% to $32.1 million in 2025.
- Business Quant data shows PLUR's Assets Average at $32.1 million in Q4 2025, $36.2 million in Q3 2025, and $38.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 32.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.13 Mn |
| Sep 30, 2025 | 36.18 Mn |
| Jun 30, 2025 | 38.05 Mn |
| Mar 31, 2025 | 34.13 Mn |
| Dec 31, 2024 | 33.15 Mn |
| Sep 30, 2024 | 37.48 Mn |
| Jun 30, 2024 | 37.96 Mn |
| Mar 31, 2024 | 38.98 Mn |
| Dec 31, 2023 | 43.05 Mn |
| Sep 30, 2023 | 47.67 Mn |
| Jun 30, 2023 | 53.52 Mn |
| Mar 31, 2023 | 58.08 Mn |
| Dec 31, 2022 | 59.84 Mn |
| Sep 30, 2022 | 63.91 Mn |
| Jun 30, 2022 | 73.60 Mn |
| Mar 31, 2022 | 80.16 Mn |
| Dec 31, 2021 | 82.47 Mn |
| Sep 30, 2021 | 88.64 Mn |
| Jun 30, 2021 | 86.36 Mn |
| Mar 31, 2021 | 65.72 Mn |